(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(0.24%) $79.14
(0.20%) $2.04
(0.18%) $2 313.70
(0.32%) $26.92
(0.02%) $962.80
(-0.13%) $0.932
(-0.43%) $10.98
(-0.11%) $0.798
(-2.29%) $91.12
@ $0.419
Issued: 13 Feb 2024 @ 10:41
Return: 1 640.27%
Live Chart Being Loaded With Signals
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract...
Stats | |
---|---|
Today's Volume | 300 885 |
Average Volume | 1.14M |
Market Cap | 88.43M |
EPS | $0 ( 2024-03-27 ) |
Next earnings date | ( $-4.80 ) 2024-05-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 22.78 |
ATR14 | $0.0490 (0.67%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-11 | Finley John David | Buy | 5 558 | Common Stock, par value $0.01 |
2024-03-11 | Finley John David | Sell | 5 558 | Restricted Stock Units |
2024-02-09 | Neal James R | Buy | 12 160 | Common Stock Options |
2024-02-09 | Neal James R | Buy | 5 820 | Common Stock, par value $0.01 |
2024-02-09 | Neal James R | Buy | 6 880 | Common Stock Options |
INSIDER POWER |
---|
33.99 |
Last 100 transactions |
Buy: 569 716 | Sell: 281 847 |
Volume Correlation
Palisade Bio, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Palisade Bio, Inc. Correlation - Currency/Commodity
Palisade Bio, Inc. Financials
Annual | 2022 |
Revenue: | $0 |
Gross Profit: | $-167 000 (0.00 %) |
EPS: | $-14.54 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-167 000 (0.00 %) |
EPS: | $-14.54 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-109.92 |
FY | 2020 |
Revenue: | $13 520.00 |
Gross Profit: | $13 520.00 (100.00 %) |
EPS: | $-293.16 |
Financial Reports:
No articles found.
Palisade Bio, Inc.
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor that is intended to inhibit digestive enzyme activity and preserve gut integrity during intestinal stress resulting from reduced blood flow to the intestine, infections, or due to surgery. The company was founded in 2005 and is headquartered in Carlsbad, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators